BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 7033028)

  • 1. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

  • 2. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunopathology in lymphatic systemic diseases].
    Huber H; Huber C; Michlmayr G
    Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
    Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
    Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune deficiency in malignant lymphomas.
    Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
    Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunodeficiencies and lymphomas].
    Montroni M
    Minerva Med; 1982 Apr; 73(15):929-34. PubMed ID: 7043315
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 11. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G; Augener W; Douglas SD; König E; Brittinger G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract]   [Full Text] [Related]  

  • 12. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular immune responses and prognosis in malignant lymphomas.
    Sokal JE; Aungst CW
    Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic markers of non-Hodgkin's lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
    [No Abstract]   [Full Text] [Related]  

  • 16. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytotoxic antibodies in hematosarcomas].
    Moulinier J; Hoerni B; Merle MC; Mothey C
    Bord Med; 1972 Jun; 5(11):1291-4. PubMed ID: 4560012
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic characterization of human malignant lymphomas.
    Lukes RJ; Collins RD
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1488-503. PubMed ID: 4608683
    [No Abstract]   [Full Text] [Related]  

  • 19. Total and 'active' E-rosette forming T lymphocytes in case of lymphoma: a preliminary communication.
    Kumar R; Sharma VK; Goel S; Mehrotra ML; Nagar AM
    Indian J Cancer; 1986 Sep; 23(3):185-91. PubMed ID: 3497863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of immunoglobulin in malignant lymphoma].
    Isobe T; Kato T
    Saishin Igaku; 1968 Nov; 23(11):2454-9. PubMed ID: 4180058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.